245 related articles for article (PubMed ID: 28249571)
1. Evaluating segmental liver function using T1 mapping on Gd-EOB-DTPA-enhanced MRI with a 3.0 Tesla.
Zhou ZP; Long LL; Qiu WJ; Cheng G; Huang LJ; Yang TF; Huang ZK
BMC Med Imaging; 2017 Mar; 17(1):20. PubMed ID: 28249571
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of liver function in patients with chronic hepatitis B using Gd-EOB-DTPA-enhanced T1 mapping at different acquisition time points: a feasibility study.
Li J; Cao B; Bi X; Chen W; Wang L; Du Z; Zhang X; Yu X
Radiol Med; 2021 Sep; 126(9):1149-1158. PubMed ID: 34105102
[TBL] [Abstract][Full Text] [Related]
3. Comparison of 10- and 20-min hepatobiliary phase images on Gd-EOB-DTPA-enhanced MRI T1 mapping for liver function assessment in clinic.
Zhou ZP; Long LL; Qiu WJ; Cheng G; Huang LJ; Yang TF; Huang ZK
Abdom Radiol (NY); 2017 Sep; 42(9):2272-2278. PubMed ID: 28396918
[TBL] [Abstract][Full Text] [Related]
4. Estimation of liver function using T1 mapping on Gd-EOB-DTPA-enhanced magnetic resonance imaging.
Katsube T; Okada M; Kumano S; Hori M; Imaoka I; Ishii K; Kudo M; Kitagaki H; Murakami T
Invest Radiol; 2011 Apr; 46(4):277-83. PubMed ID: 21343827
[TBL] [Abstract][Full Text] [Related]
5. Gd-EOB-DTPA-enhanced MRI T1 mapping for assessment of liver function in rabbit fibrosis model: comparison of hepatobiliary phase images obtained at 10 and 20 min.
Zhou ZP; Long LL; Huang LJ; Yang TF; Huang ZK
Radiol Med; 2017 Apr; 122(4):239-247. PubMed ID: 28070844
[TBL] [Abstract][Full Text] [Related]
6. Assessing liver function in patients with HBV-related HCC: a comparison of T₁ mapping on Gd-EOB-DTPA-enhanced MR imaging with DWI.
Ding Y; Rao SX; Chen C; Li R; Zeng MS
Eur Radiol; 2015 May; 25(5):1392-8. PubMed ID: 25523455
[TBL] [Abstract][Full Text] [Related]
7. Quantitative evaluation of liver function with T1 relaxation time index on Gd-EOB-DTPA-enhanced MRI: comparison with signal intensity-based indices.
Kamimura K; Fukukura Y; Yoneyama T; Takumi K; Tateyama A; Umanodan A; Shindo T; Kumagae Y; Ueno S; Koriyama C; Nakajo M
J Magn Reson Imaging; 2014 Oct; 40(4):884-9. PubMed ID: 24677659
[TBL] [Abstract][Full Text] [Related]
8. Assessment of clinical signs of liver cirrhosis using T1 mapping on Gd-EOB-DTPA-enhanced 3T MRI.
Haimerl M; Verloh N; Zeman F; Fellner C; Müller-Wille R; Schreyer AG; Stroszczynski C; Wiggermann P
PLoS One; 2013; 8(12):e85658. PubMed ID: 24392025
[TBL] [Abstract][Full Text] [Related]
9. Development and validation of a predictor of insufficient enhancement during the hepatobiliary phase of Gd-EOB-DTPA-enhanced magnetic resonance imaging.
Cui E; Long W; Luo L; Hu M; Huang L; Chen X
Acta Radiol; 2017 Oct; 58(10):1174-1181. PubMed ID: 28090793
[TBL] [Abstract][Full Text] [Related]
10. Impact of liver cirrhosis on liver enhancement at Gd-EOB-DTPA enhanced MRI at 3 Tesla.
Verloh N; Haimerl M; Rennert J; Müller-Wille R; Nießen C; Kirchner G; Scherer MN; Schreyer AG; Stroszczynski C; Fellner C; Wiggermann P
Eur J Radiol; 2013 Oct; 82(10):1710-5. PubMed ID: 23806531
[TBL] [Abstract][Full Text] [Related]
11. Usefulness of T1 mapping on Gd-EOB-DTPA-enhanced MR imaging in assessment of non-alcoholic fatty liver disease.
Ding Y; Rao SX; Meng T; Chen C; Li R; Zeng MS
Eur Radiol; 2014 Apr; 24(4):959-66. PubMed ID: 24463697
[TBL] [Abstract][Full Text] [Related]
12. T
Yang L; Ding Y; Rao S; Chen C; Zeng M
J Magn Reson Imaging; 2021 Mar; 53(3):896-902. PubMed ID: 32979019
[TBL] [Abstract][Full Text] [Related]
13. T1 mapping combined with Gd-EOB-DTPA-enhanced magnetic resonance imaging in predicting the pathologic grading of hepatocellular carcinoma.
Chen CY; Chen J; Xia CC; Huang ZX; Song B
J Biol Regul Homeost Agents; 2017; 31(4):1029-1036. PubMed ID: 29254310
[TBL] [Abstract][Full Text] [Related]
14. MR liver imaging with Gd-EOB-DTPA: The need for different delay times of the hepatobiliary phase in patients with different liver function.
Liang M; Zhao J; Xie B; Li C; Yin X; Cheng L; Wang J; Zhang L
Eur J Radiol; 2016 Mar; 85(3):546-52. PubMed ID: 26860666
[TBL] [Abstract][Full Text] [Related]
15. Quantitative assessment of hepatic fibrosis in chronic hepatitis B and C: T1 mapping on Gd-EOB-DTPA-enhanced liver magnetic resonance imaging.
Pan S; Wang XQ; Guo QY
World J Gastroenterol; 2018 May; 24(18):2024-2035. PubMed ID: 29760545
[TBL] [Abstract][Full Text] [Related]
16. Liver function correlates with liver-to-portal vein contrast ratio during the hepatobiliary phase with Gd-EOB-DTPA-enhanced MR at 3 Tesla.
Zhang W; Wang X; Miao Y; Hu C; Zhao W
Abdom Radiol (NY); 2018 Sep; 43(9):2262-2269. PubMed ID: 29476347
[TBL] [Abstract][Full Text] [Related]
17. Assessing liver function by liver enhancement during the hepatobiliary phase with Gd-EOB-DTPA-enhanced MRI at 3 Tesla.
Verloh N; Haimerl M; Zeman F; Schlabeck M; Barreiros A; Loss M; Schreyer AG; Stroszczynski C; Fellner C; Wiggermann P
Eur Radiol; 2014 May; 24(5):1013-9. PubMed ID: 24531844
[TBL] [Abstract][Full Text] [Related]
18. Optimization of hepatobiliary phase delay time of Gd-EOB-DTPA-enhanced magnetic resonance imaging for identification of hepatocellular carcinoma in patients with cirrhosis of different degrees of severity.
Wu JW; Yu YC; Qu XL; Zhang Y; Gao H
World J Gastroenterol; 2018 Jan; 24(3):415-423. PubMed ID: 29391764
[TBL] [Abstract][Full Text] [Related]
19. Hepatic enhancement of Gd-EOB-DTPA-enhanced 3 Tesla MR imaging: Assessing severity of liver cirrhosis.
Lee S; Choi D; Jeong WK
J Magn Reson Imaging; 2016 Nov; 44(5):1339-1345. PubMed ID: 27197633
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of liver function using liver parenchyma, spleen and portal vein signal intensities during the hepatobiliary phase in Gd-EOB-D TPA-enhanced MRI.
Yang M; Zhang Y; Zhao W; Cheng W; Wang H; Guo S
BMC Med Imaging; 2020 Oct; 20(1):119. PubMed ID: 33081713
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
